ASNR 2023
Attending ASNR 2023? Stop by booth 603 to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
MRI quantification: What you need to know when reading dementia and MS cases
Join our webinar on April 27, 2023, to hear Dr. Kevin Berger share his insights on the value of using MRI quantification and lesion detection.
Garmisch Symposium International 2023
Attending Garmisch Symposium International 2023? Visit us at booth B8 to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
BioCapital Europe 2023
At BioCapital Europe 2023, our CEO, Richard Hausmann, will discuss our company history and development of our cNeuro® suite.
cMRI Now Available Through TeraRecon’s Eureka Clinical AI Platform
cMRI is now available through TeraRecon's Eureka Clinical AI platform, an AI solution for imaging analysis spanning neurology, oncology, pulmonology, and cardiology.
Imaging biomarkers play a crucial role in the development, approval, and use of disease-modifying drugs for Alzheimer’s disease
Biomarkers, including imaging biomarkers, will be important for managing patients with Alzheimer's disease on disease-modifying drugs (DMD), such as Aduhelm and Leqembi, across the patient pathway.
ECR 2023
Attending ECR 2023? Stop by our booth to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
Optimizing cCOG, a Web‐based tool, to detect dementia with Lewy bodies
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring A.M. van Gils, M. van de Beek,…
In radiology, AI has moved from a buzzword to a valuable tool: RSNA 2022
AI in radiology is here to stay. The next challenge is ensuring it’s seamlessly integrated into radiologists’ and technicians’ imaging workflows. Read about these and other takeaways from RSNA 2022 in this blog post from Richard Hausmann, CEO; Lennart Thurfjell, COO; and Greg Kingston, CMO.
Combinostics to Showcase Comprehensive Solutions for the Entire Patient Care Pathway of Neurological Disorders at RSNA
New and existing tools, including cPET, cARIA, and the Dementia Differential Analysis report, extend Combinostics’ solution beyond neurological image quantification and support end-to-end workflows.
